DAVIS, ERIC,ODONNELL, JOHN,BOTTINI, PETER BRUCE,MASON, PRESTON,SHAW, ANDREW PRESTON
申请号：
HK15105173.1
公开号：
HK1204570A
申请日:
2008.04.22
申请国别(地区):
HK
年份:
2015
代理人:
摘要：
Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other cardiovascular agent, wherein the at least one other cardiovascular agent is an angiotesin II receptor antagonist.
